How have COT shares performed in 2024?

Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.04 on January 1st, 2024. Since then, COT shares have increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here .

Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock?

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cotinga Pharmaceuticals Inc. (COT.V) investors own include Cascades (CAS) , Aurora Cannabis (ACB) , Advantage Lithium Corp. (AAL.V) (AAL) , InPlay Oil (IPO) , Harvest One Cannabis (HVT) , Exchange Income (EIF) , Datametrex AI (DM) , Canadian National Railway (CNI) and Alimentation Couche-Tard (ATD.B) .

How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?

Shares of COT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:COT

Cotinga Pharmaceuticals Inc. (COT.V) (COT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free COT Stock Alerts

C$0.04

-0.03 (-41.67%)

(As of 10/14/2020)

Compare

Today's Range: C$0.04
▼
C$0.04
50-Day Range: C$0.04
▼
C$0.04
52-Week Range: C$0.02
▼
C$0.12

Volume: 1,000 shs
Average Volume: 20,281 shs
Market Capitalization: C$769,510.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Cotinga Pharmaceuticals Inc. (COT.V) alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Cotinga Pharmaceuticals Inc. (COT.V)

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

COT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

COT Stock News Headlines

February 14, 2024 | wsj.com

Lexicon Pharmaceuticals Inc.

November 5, 2023 | morningstar.com

Acumen Pharmaceuticals Inc ABOS

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

July 22, 2023 | seekingalpha.com

SXTP 60 Degrees Pharmaceuticals, Inc.

April 28, 2023 | marketwatch.com

8-K: ENANTA PHARMACEUTICALS INC

February 18, 2023 | seekingalpha.com

Ironwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation

January 24, 2023 | seekingalpha.com

PTPI Petros Pharmaceuticals, Inc.

October 11, 2022 | wsj.com

Amylyx Pharmaceuticals Inc.

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

August 12, 2022 | yahoo.com

PepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

May 26, 2022 | finance.yahoo.com

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

See More Headlines

Receive COT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals Inc. (COT.V) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:COT
CUSIP: N/A
CIK: N/A
Web: cotingapharma.com
Phone: +1-519-8585157
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.05
Quick Ratio: 0.01

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 17.50
Book Value: C($0.18) per share
Price / Book: -0.20

Miscellaneous

Outstanding Shares: 21,986,000
Free Float: N/A
Market Cap: C$769,510.00
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Ms. Alison D. Silva
CEO, Pres & Director
Dr. Richard T. Ho (Age 58)
Chief Scientific Officer
Comp: $323.16k
Mr. Victor Hugo C.M.A. (Age 51)
C.P.A., Chief Financial Officer
Mr. Paul Papi
VP of Investor Relations

Key Competitors

View All Competitors

COT Stock Analysis - Frequently Asked Questions

How have COT shares performed in 2024?: Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.04 on January 1st, 2024. Since then, COT shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here.
Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock?: Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%.
What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cotinga Pharmaceuticals Inc. (COT.V) investors own include Cascades (CAS), Aurora Cannabis (ACB), Advantage Lithium Corp. (AAL.V) (AAL), InPlay Oil (IPO), Harvest One Cannabis (HVT), Exchange Income (EIF), Datametrex AI (DM), Canadian National Railway (CNI) and Alimentation Couche-Tard (ATD.B).
How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?: Shares of COT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:COT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial